Interparfums Inc

This proposal asks shareholders to cast a non-binding advisory vote to approve the company’s disclosed executive compensation for named executive officers. Management frames the vote as a routine 'say-on-pay' required under Dodd-Frank and stresses that the Compensation Committee has designed pay arrangements to align executive incentives with long-term shareholder interests, combining base salary, discretionary bonuses and long-term equity-based awards. The Board seeks a positive endorsement to reinforce its approach to executive pay, citing the Compensation Committee’s view that compensation is market-competitive and targeted to retain and motivate key executives. Although the vote is advisory and not legally binding, the Board and Compensation Committee state they will consider the outcome when shaping future pay decisions. The company notes historical context that the prior advisory vote in 2025 was overwhelmingly approved, which management interprets as shareholder support for existing practices. From a governance standpoint, shareholders should weigh the advisory nature, the company’s governance structures (an independent Compensation Committee) and potential conflicts given long-tenured executive-shareholders who also receive fees through holding companies. The proposal provides transparency through CD&A and compensation tables, but investors may evaluate pay-for-performance alignment given the company’s recent financial results and dividend policy. The Board’s recommendation to vote FOR is based on its judgment that current compensation policies support retention, performance and alignment with shareholder value creation. Given the non-binding nature, a strong vote against would typically trigger engagement and potential revisions by the Compensation Committee; a strong vote for provides endorsement of current practice.

This management proposal requests shareholder approval to amend and extend the term of the company's 2016 Stock Option Plan by ten years because the plan expired on June 27, 2026. Management argues that the plan is a key tool to attract and retain directors, officers, key employees and consultants and to align their interests with shareholders by granting incentive and nonqualified stock options and stock appreciation rights. The amendment does not seek to increase the aggregate share reserve or materially change eligibility or benefits; it solely extends the period during which awards may be granted, preserving the plan's existing structure and administrative provisions. The plan permits up to 1,000,000 shares (subject to anti-dilution adjustments) and currently has 451,535 shares available for future grants, and nonemployee directors receive automatic annual option grants under specified terms. The Board and a committee of independent directors administer the plan, and the proposal notes tax and Section 162(m) considerations, including that certain awards may qualify as performance-based compensation. Shareholder approval is required under the charter to extend the grant period, and the Board emphasizes that affiliates intend to vote in favor and that approval requires a majority of votes cast at the meeting. From a governance perspective, investors should weigh the retention and incentive benefits against potential dilution from additional awards and consider the company’s disclosure around allocation, vesting, repooling of returned shares, and share usage. The Board’s unanimous recommendation and the explicit detail about limits and administration reduce some governance risk, but investors may still evaluate grant practices, overlap with Interparfums SA plans, and historical grant pacing before supporting the extension.